Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 11, 2016 - Issue
Submit an article Journal homepage
48
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study

Rüdiger Sauer1 Lung Centre Ulm, Ulm, Germany
,
Michaela Hänsel2 Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
,
Roland Buhl3 Pulmonary Department, Mainz University Hospital, Mainz, Germany
,
Roman A Rubin4 Pulmonary Specialist Practice, Wiesbaden, Germany
,
Marcel Frey5 Biometrics, Alcedis GmbH, Gießen, Germany
&
Thomas Glaab2 Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany;3 Pulmonary Department, Mainz University Hospital, Mainz, GermanyCorrespondence[email protected]
Pages 891-898 | Published online: 27 Apr 2016

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Dave Singh, Anthony D D’Urzo, James F Donohue, Edward M Kerwin, Eduard Molins, Ferran Chuecos, Anna Ribera & Diana Jarreta. (2019) An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2835-2848.
Read now
Arschang Valipour, Michael Tamm, Jana Kociánová, Valentina Bayer, Maria Sanzharovskaya, Alexey Medvedchikov, Monika Haaksma-Herczegh, János Mucsi, Zvi Fridlender, Claudia Toma, Andrey Belevskiy, Bohumil Matula & Jurij Šorli. (2019) Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2343-2354.
Read now
Karl-Otto Steinmetz, Birgit Abenhardt, Stefan Pabst, Michaela Hänsel, Anke Kondla, Valentina Bayer & Roland Buhl. (2019) Assessment of physical functioning and handling of tiotropium/olodaterol Respimat® in patients with COPD in a real-world clinical setting. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1441-1453.
Read now
Martine Hoogendoorn, Isaac Corro Ramos, Michael Baldwin, Laura Luciani, Cecile Fabron, Bruno Detournay & Maureen P M H Rutten-van Mölken. (2019) Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 447-456.
Read now
Gary T. Ferguson & Richard N. Dalby. (2018) Clinical implications of the tiotropium/olodaterol inhaler for patients with chronic obstructive pulmonary disease. Postgraduate Medicine 130:6, pages 515-522.
Read now
Job FM van Boven, Janwillem WH Kocks & Maarten J Postma. (2016) Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2191-2201.
Read now

Articles from other publishers (1)

Marc Miravitlles, Juan Luís García-Rivero, Xavier Ribera, Jordi Galera, Alejandra García, Rosa Palomino & Xavier Pomares. (2022) Exercise capacity and physical activity in COPD patients treated with a LAMA/LABA combination: a systematic review and meta-analysis. Respiratory Research 23:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.